Cargando…
Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study
Abnormalities in the expression of metabotropic glutamate receptor type 5 (mGluR5) have been observed in the hippocampus of patients with drug-resistant mesial Temporal Lobe Epilepsy (mTLE). Ex-vivo studies in mTLE hippocampal surgical specimens have shown increased mGluR5 immunoreactivity, while in...
Autores principales: | Zimmermann, Maria, Minuzzi, Luciano, Aliaga Aliaga, Arturo, Guiot, Marie-Christine, Hall, Jeffery A., Soucy, Jean-Paul, Massarweh, Gassan, El Mestikawy, Salah, Rosa-Neto, Pedro, Kobayashi, Eliane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355376/ https://www.ncbi.nlm.nih.gov/pubmed/35937057 http://dx.doi.org/10.3389/fneur.2022.888479 |
Ejemplares similares
-
Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans
por: Smart, Kelly, et al.
Publicado: (2021) -
Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [(11)C]ABP688 Positron-Emission Tomography (PET) Imaging
por: DuBois, Jonathan M., et al.
Publicado: (2016) -
Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia
por: DuBois, Jonathan M., et al.
Publicado: (2020) -
Reverse engineering of metabotropic glutamate receptor-dependent long-term depression in the hippocampus
por: Tambuyzer, Tim, et al.
Publicado: (2011) -
Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone
por: R Zimmer, Eduardo, et al.
Publicado: (2015)